Atlas Trials

A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age

Clinical trial NCT00860067 · COMPLETED

Trial details

NCT number
NCT00860067
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Healthy or Stable Underlying Chronic Medical Condition
Start date
2009-03-01
Primary completion
2009-05-01
Enrollment
1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.